NCT00381251
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Hot Flashes, +9 more
- Locations
-
Not specified
Clinical trial condition
Osteoporosis
Explore clinical trials studying Osteoporosis. Study availability and eligibility vary by location and protocol.
171 public trials
7 recruiting studies
Osteoporosis trial results
NCT00079924
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntsville, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
NCT00035256
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Maywood, Illinois, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Portland, Oregon, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kitchener, Ontario, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician London, Ontario, Canada
NCT00085956
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States
NCT00046137
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". Anaheim, California, United States
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". Oakland, California, United States
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". Altamonte Springs, Florida, United States
- "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". Chicago, Illinois, United States
Active, Not Recruiting
Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
NCT05575167
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- Univ. Lille, CHU Lille Lille, France
- 251 Hellenic Airforce and VA General Hospital Athens, Greece
- First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens Athens, Greece
- , KAT General Hospital Athens, Greece
Active, Not Recruiting
Dried Plums and Bone Health in Postmenopausal Women
NCT02822378
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- Women's Health and Exercise Laboratories, The Pennsylvania State University University Park, Pennsylvania, United States
Active, Not Recruiting
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
NCT04467983
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- Hospital for Special Surgery New York, United States
Active, Not Recruiting
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)
NCT05655013
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark